22.11.2014 Views

RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden

RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden

RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

BIBLIOGRAFÍA<br />

68. Harvey JM, Howie AJ, Lee SJ, Newbold KM, Adu D, Michael<br />

J, y cols. Renal biopsy findings in hypertensive patient with<br />

proteinuria. Lancet 340:1435-1436, 1992.<br />

69. Luke RG: Hypertensive nephrosclerosis: pathogenesis and<br />

prevalence. Nephrol Dial Transplant 14:2271-2278, 1999.<br />

70. Egido J: Vasoactive hormones and renal sclerosis. Kidney Int<br />

49: 578-597, 1996.<br />

71. Wardle EN: Renal collagen synthesis and its control.<br />

Nephron 83: 106-110, 1999.<br />

72. Isaka Y, Akagi Y, Ando Y, Tsujie M, Imai E: Cytokines and glomerulosclerosis.<br />

Nephrol Dial Transplant 14: 30-32 1999.<br />

73. Luft FC: Hypertensive nephrosclerosis-a cause of end stage<br />

renal disease ? Nephrol Dial Transplant 15: 1515-1517,<br />

2000.<br />

74. Brown DM, Provoost AP, Daly MJ, Lander ES, Jacob HJ:<br />

Renal disease susceptibility and hypertension are under<br />

independent genetic control in the fawn-hooded rat. Nature<br />

Genet 12: 44-51, 1996.<br />

75. Bergman S, Key BO, Kirk KA, Warnock DG, Rostand SG:<br />

Kidney disease in the first-degree relatives of African-<br />

Americans with hypertensive end-stage renal disease. Am J<br />

Kidney Dis 27: 341-346, 1996.<br />

76. O`Dea DF, Murphy SW, Hefferton D, Parkfrey PS: Higher risk<br />

for renal failure in first-degree relatives of white patients with<br />

end-stage renal disease: A population based study. Am J<br />

Kidney Dis 32: 794-801, 1998.<br />

77. Marcantoni C, Ma L-J, Federspiel C, Fogo AB: Hypertensive<br />

nephrosclerosis in African Americans versus Caucasians.<br />

Kidney Int 62: 172-180, 2002.<br />

78. Hollenberg NK: Renal function in the patient with hypertension.<br />

Med Clin North Am 88: 131-140, 2004.<br />

79. Kincaid-Smith P: Hypothesis: Obesity and the insulin resistance<br />

syndrome play a major role in end-stage renal failure<br />

attributed to hypertension and labelled ‘hypertensive nephrosclerosis’.<br />

J Hypertens 22: 1051-1055, 2004.<br />

80. Andronico G, Ferraro-Monterello R, Mangano MT, Rome M,<br />

Rasputi F, Pinto A, y cols. Insulin resistance and glomerular<br />

haemodynamics and essential hipertensión. Kidney Int 62:<br />

1005-1009, 2002.<br />

81. Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V,<br />

Whelton PK, y cols. Insulin resistance and risk of chronic<br />

kidney disease in non-diabetic US adults. J Am Soc Nephrol<br />

14: 469-477, 2003.<br />

82. Bloch MJ, Basile J: The diagnosis and management of renovascular<br />

disease: a primary care perspective. Part I. Making<br />

the diagnosis. J Clin Hypertens 5: 210-218, 2003.<br />

83. Zoccali C, Mallamaci F, Finocchiaro P: Atherosclerotic renal<br />

artery stenosis: epidemiology, cardiovascular outcomes, and<br />

clinical prediction rules. J Am Soc Nephrol 13 (Suppl 3):<br />

S179-S183, 2002.<br />

84. Nally JV, Barton DP: Contemporary approach to diagnosis<br />

and evaluation of renovascular hypertension. Urol Clin<br />

North Am 28: 781-791, 2001.<br />

85. Lerman L, Textor SC: Pathophysiology of ischemic nephropathy.<br />

Urol Clin North Am 28: 793-803, 2001.<br />

86. Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes<br />

BM, Mossey RT: Renal vascular disease causing end-stage<br />

renal disease, incidence, clinical correlates, and outcomes:<br />

A 20-year clinical experience. Am J Kidney Dis 24: 622-629,<br />

1994.<br />

87. Murphy TP, Rundback JH, Cooper C, Kiernan MS: Chronic<br />

renal ischemia: implications for cardiovascular disease risk.<br />

J Vasc Interv Radiol 13: 1187-1198, 2002.<br />

88. Modi K, Rao VK: Atheroembolic renal disease. J Am Soc<br />

Nephrol 12: 1781-1787, 2001.<br />

89. Scoble JE: Atherosclerotic nephropathy. Kidney Int Suppl: 56<br />

(Suppl 71): S106-S109; 1999.<br />

90. Coresh J, Astor B, Sarnak MJ: Evidence for increased cardiovascular<br />

disease risk in patients with chronic kidney disease.<br />

Curr Opin Nephrol Hypertens 13: 73-81, 2004<br />

91. Keane WF, Eknoyan G: Proteinuria, albuminuria, risk, assessment,<br />

detection, elimination (PARADE): a position paper of<br />

the National Kidney Foundation. Am J Kidney Dis 33: 1004-<br />

1010, 1999.<br />

92. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS:<br />

Prevalence of chronic kidney disease and decreased kidney<br />

function in the adult US population: Third National Health<br />

and Nutrition Examination Survey. Am J Kidney Dis 41: 1-<br />

12, 2003.<br />

93. McClellan WM, Knight DF, Karp H, Brown WW: Early detection<br />

and treatment of renal disease in hospitalized diabetic<br />

and hypertensive patients: important differences between<br />

practice and published guidelines. Am J Kidney Dis 29: 368-<br />

375, 1997.<br />

94. Locatelli F, Del Vecchio L, Pozzoni P: The importance of<br />

early detection of chronic kidney disease. Nephrol Dial<br />

Transplant 17: S2-S7, 2002.<br />

95. Remuzzi G, Ruggenenti P, Perico N: Chronic renal diseases:<br />

renoprotective benefits of renin-angiotensin system inhibition.<br />

Ann Intern Med 136: 604-615, 2002.<br />

96. Rossert J, Fouqueray B, Jacques Boffa J: Anemia management<br />

and delay of chronic renal failure progression. J Am Soc<br />

Nephrol 14: S173-S177, 2003.<br />

97. Górriz JL, Sancho A, Pallardó LM, Amoedo ML, Martín M,<br />

Sanz P, y cols. Significado pronóstico de la diálisis programada<br />

en pacientes que inician tratamiento sustitutivo renal.<br />

Un estudio multicéntrico español. Nefrología 22: 49-59,<br />

2002.<br />

98. De Francisco ALM, Fernández-Fresnedo G: Llegada tardía a<br />

diálisis como consecuencia de insuficiencia renal no identificada.<br />

Nefrología 22: 95-97, 2002.<br />

99. Levinsky NG: Specialist evaluation in chronic kidney disease:<br />

too little, too late. Ann Intern Med 137: 542-543, 2002.<br />

100. Obrador GT, Arora P, Kausz AT, Ruthazer R, Pereira BJ, Levey<br />

AS: Level of renal function at the initiation of dialysis in the<br />

U.S. end-stage renal disease population. Kidney Int 56:<br />

2227-2235, 1999.<br />

101. United States Renal Data System: Excerpts from the 2000<br />

U.S. Renal Data System Annual Data Report: Atlas of End<br />

Stage Renal Disease in the United States. Am J Kidney Dis<br />

36: S1-S279, 2000.<br />

102. Stengel B, Billon S, van Dijk PCW, Jager KJ, Dekker FW,<br />

Simpson K, y cols. on behalf of the ERA-EDTA Registry<br />

Committee: Trends in the incidence of renal replacement<br />

therapy for end-stage renal disease in Europe, 1990-1999.<br />

Nephrol Dial Transplant 18: 1824-1833, 2003.<br />

103. Amenábar JJ, García F, Robles NR, Saracho R, Pinilla J,<br />

Gentil MA, y cols. Informe de diálisis y trasplante de la<br />

Sociedad Española de Nefrología y Registros Autonómicos,<br />

año 2000. Nefrología 22: 310-317, 2002.<br />

189

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!